
- Pharmaceutical Executive-08-01-2002
East Meets West
Croatia's Pliva Pharmaceuticals is the first eastern European pharma company to make a US acquisition. Pliva paid $153 million for New Jersey-based Sobel Holdings,
Croatia's Pliva Pharmaceuticals is the first eastern European pharma company to make a US acquisition. Pliva paid $153 million for New Jersey-based Sobel Holdings, which owns Sidmak, a generics maker, and Odyssey, a specialty brand-name pharma company with products such as Urecholine (bethanechol) for non-obstructive urinary retention; Vivactil (protryptylline) and Surmontil (trimipramine) for depression; Antabuse (disulfiram) for alcohol abuse; Nystatin vaginal tablets (for candidiasis); and Custodol HTK solution for the preservation of donor organs.
In addition to the company's product rights and trademarks, the deal gives Pliva an established US distribution network and a product development and manufacturing plant in East Hanover, New Jersey.
Articles in this issue
over 24 years ago
Elan Hits Bottomover 24 years ago
Go With the Flowover 24 years ago
Pfizer Buys Another Marketing Partnerover 24 years ago
Drug Info War Heats Upover 24 years ago
Not So NICEover 24 years ago
Internet to the Rescueover 24 years ago
Policing CRM Samplingover 24 years ago
House Adopts Medicare Rx BenefitRelated to this article








